Benzinga's Top Downgrades - Citigroup (NYSE:C), Fox (NASDAQ:FOXA)

Goldman Sachs downgraded Citigroup Inc C from Buy to Neutral. The price target for Citigroup has been lowered from $52 to $50. Citigroup shares fell 1.13 percent to $46.55 in pre-market trading.
JP Morgan downgraded Novavax, Inc. NVAX from Overweight to Neutral. Novavax shares tumbled 85.85 percent to $1.18 in pre-market trading.
Analysts at Atlantic Equities downgraded Wells Fargo & Co WFC from Neutral to Underweight. Wells Fargo shares dropped 0.41 percent to $45.96 in pre-market trading.
Cowen & Co. downgraded Horizon Pharma PLC HZNP from Outperform to Market Perform. Horizon Pharma shares declined 0.25 percent to close at $19.58 on Thursday.
Analysts at Goldman Sachs downgraded McKesson Corporation MCK from Buy to Neutral. The price target for McKesson has been lowered from $210 to $189. McKesson shares fell 0.87 percent to $167.50 in pre-market trading.
Bank of America downgraded Guidewire Software Inc GWRE from Neutral to Underperform. Guidewire Software shares gained 0.39 percent to close at $61.17 on Thursday.
Analysts at Bernstein downgraded Twenty-First Century Fox Inc FOXA from Outperform to Market Perform. Twenty-First Century Fox shares declined 1.22 percent to $23.55 in pre-market trading.
Analysts at Cowen & Co. downgraded Raptor Pharmaceutical Corp. RPTP from Outperform to Market Perform. Raptor Pharmaceutical shares rose 0.22 percent to close at $8.98 on Thursday.
Citigroup downgraded Novavax, Inc. NVAX from Buy to Neutral. The price target for Novavax has been lowered from $12 to $1.50. Novavax shares fell 85.85 percent to $1.18 in pre-market trading.

Market News and Data brought to you by Benzinga APIs